HEART FAILURE BWGHF

The official Belgian Working Group on #HeartFailure (BWGHF).
This Working Group was created in 2004. #hartfalen #Insuffisancecardiaque

[HEART FAILURE BWGHF @BWGHF]

#BreakingNews PRAISE-MR trial (@S_Dhont 🇧🇪)
First RCT in atrial functional MR (#AFMR) with #HFpEF
Could AFMR be a treatable condition?
#HeartFailure
#HeartFailure26
1/3 thread @WilfriedMullens @HFA_President

[HEART FAILURE BWGHF @BWGHF]

🚀 Webinaire: L'IA en Insuffisance Cardiaque ! Rejoignez-nous pour une discussion approfondie sur l'impact de l'intelligence artificielle dans notre pratique quotidienne.
📅 Jeudi 21 mai
⏰ 19h30 - 20h45
📍 Online #AI
#heartfailure https://t.co/ud9WYbhBQQ

[Ahmed Bennis MD 🫀 @drbennisahmed]

��� RELIEVE-HF data at #HeartFailure26 gets more striking with the Kaplan-Meier curves:
HFrEF (shunt vs control):
↘️ 51% hazard reduction (HR 0.49, 95% CI 0.35–0.65)
76 vs 134 events — curves diverge early & keep separating
HFpEF (shunt vs control):
↗️ 69% hazard increase (HR 1.69, 95% CI 1.29–2.27)
143 vs 88 events — shunt clearly harmful
Interaction p<0.0001 — this is not noise.
Interatrial shunting: a game-changer for HFrEF, a harm signal in HFpEF. Phenotype selection is everything. 🎯
#RELIEVEHF #HeartFailure #HFrEF #HFpEF #Cardiology #HF2026

[Novi Yanti Sari @slumberbell]

🫀 What happens when long-term low-dose #digoxin is suddenly withdrawn?
Blinded withdrawal analysis from the #DECISION trial presented at #HeartFailure26 by Prof. Peter van der Meer:

📍Digoxin withdrawal was associated with a ~7x increase in worsening HF events over just 6 weeks
📍14 worsening HF events occurred after digoxin withdrawal vs only 2 events in placebo withdrawal
📍Withdrawal was accompanied by: ⬆️HR,⬇️ SBP, ⬆️NT-proBNP, ⬇️eGFR
📍⚠️caution when stopping long-term low-dose digoxin in pts with HF & LVEF <=50%

@escardio @HFA_President @jozinetm

[Jan Verwerft @VerwerftJan]

#HeartFailure2026 workshop
HF unplugged Room 1 📆Sunday 13.15
#CPETecho for suspected #HFpEF
bookmark it 📢
https://t.co/HXv55ljCxe

[European Society of Cardiology Journals @ESC_Journals]

Guideline-recommended medical therapy efficacy according to use of digoxin: RALES, EMPHASIS-HF, PARADIGM-HF, and DAPA-HF trials 👇
https://t.co/vFtJB48vg6

@FaiezZANNAD @HFA_President #HeartFailure26 #HFA_ESC

[Novi Yanti Sari @slumberbell]

🤰🫀 Adult congenital heart disease #ACHD in pregnancy requires early risk assessment, multidisciplinary planning, & individualized care, by Dr #CristinaCruz at #HeartFailure26:

��The “3 Ps” matter: pre-pregnancy counselling, preventing events & planning
📍Vaginal delivery is recommended in most women with CVD
📍Early risk assessment is crucial to evaluate maternal risk
📍Severe PAH & Eisenmenger syndrome remain among the highest-risk conditions in pregnancy
📍The Pregnancy Heart Team protects two lives: both mother & fetus

@escardio @HFA_President @MarcoMetra @jozinetm @WilfriedMullens

[Novi Yanti Sari @slumberbell]

🫀CONDUCT-AF: conduction system pacing with LBBAP vs biventricular pacing BVP in symptomatic HF patients with refractory AF undergoing AV node ablation.
presented by #DavidZizek at #HeartFailure26:

📍LBBAP was non-inferior to BVP for improvement in LVEF at 6 months
📍Both groups improved from ~35% to ~46% LVEF
📍Structural remodeling, QoL, and clinical outcomes were similar between strategies
📍LBBAP showed a more favorable procedural profile & narrower QRS
📍Represent a practical alternative to BVP in a pace-and-ablate strategy

@escardio @HFA_President @MarcoMetra @jozinetm @WilfriedMullens

[Novi Yanti Sari @slumberbell]

🤰🫀#HF in pregnancy requires balancing maternal cardiovascular stability with fetal safety at every stage, by Dr #JulieDeBacker at #HeartFailure26:

📍Pre-pregnancy counselling with risk assessment & a dedicated Pregnancy Heart Team is crucial
📍Management during pregnancy may include selected beta-blockers, hydralazine/nitrates & diuretics when clinically indicated
📍Follow-up should monitor maternal symptoms, TTE, NT-proBNP, fetal growth, placental function & amniotic fluid status
📍Early postpartum phase remains a vulnerable period, & ICU monitoring for 24-48h may be considered
📍Optimal outcomes in #cardioobstetrics start before conception & extend far beyond delivery

@escardio @HFA_President @jozinetm @MarcoMetra @WilfriedMullens

[HEART FAILURE BWGHF @BWGHF]

PRAISE-MR trial
Treatment was well tolerated
⚠️ Caveats: open-label design + surrogate endpoints
Still, PRAISE-MR suggests AFMR may be pharmacologically modifiable — an important shift
#Cardiology #HFpEF #AFMR #ARNI #HeartFailure @lamcardio @S_Dhont

[HEART FAILURE BWGHF @BWGHF]

#BreakingNews PRAISE-MR trial (@S_Dhont 🇧🇪)
First RCT in atrial functional MR (#AFMR) with #HFpEF
Could AFMR be a treatable condition?
#HeartFailure
#HeartFailure26
1/3 thread @WilfriedMullens @HFA_President

[HEART FAILURE BWGHF @BWGHF]

PRAISE-MR
💊 Sacubitril/valsartan vs standard care:
✅ ↓ exercise mPAP/CO slope (−0.93 mmHg/L/min; p=0.035)
✅ Improved peak VO₂ &amp; KCCQ
✅ ↓ NT-proBNP
✅ Better LV-GLS &amp; LAVI
→ Reverse remodeling + less dynamic MR during exercise
2/3 thread

[Jan Verwerft @VerwerftJan]

#HeartFailure2026 Hottest trials 📆13h15 Room 3
Effect of ARNi on exercise hemodynamics in HFpEF with aFMR 🫁🚴🫀
bookmark it 📢https://t.co/6p4WhSlIUb

presented by 🇧🇪 @S_Dhont
and discussed by @lamcardio

@uhasselt @MHU_LCRC
@ZOLziekenhuis @JessaZiekenhuis

[Joaquín Vila @Joaquin_VilaG]

What is HFimpEF, remHF and recHF? How do we treat these patients?

Open debate in the #HeartFailure26 ESC Congress

[Ahmed Bennis MD 🫀 @drbennisahmed]

🫀 #HFA2026 | Barcelona, May 9–12 — Most Anticipated Trials #HeartFailure26
7 late-breaking sessions, a record number of submissions, and groundbreaking data expected. Here’s what to watch 👇
🔥 Hottest Trials (1) — May 9
▸ #SUBCUTHFII — Subcutaneous furosemide for early discharge post-HF admission
▸ #REDOXAHF — Restrictive vs. liberal O₂ targets in acute HF
▸ #RePHIRE — AZD3427 (relaxin mimetic) in HF + pulmonary hypertension
▸ #PRAISEMR — Sacubitril-valsartan in HFpEF + secondary mitral regurgitation
▸ #CONDUCTAF — Conduction system vs. biventricular pacing post-AV node ablation
🔬 Innovations in HF Management — May 9
▸ #UFCARE — Ultrafiltration in cardiorenal syndrome type 2
▸ #TRANSFORMHF — Diuretic resistance strategies
▸ #TIMHF3 — Voice-based AI prediction of HF hospitalization
▸ #CARDIOTTRansform — New trial in ATTR-CM
💊 Advances in Cardiomyopathies — May 11
▸ #RESOLVEHCM — Perhexiline in hypertrophic cardiomyopathy
▸ #MAPLEHCM — Dose-dependent effects in HCM
▸ #ATTRibuteCM — Outpatient worsening HF in ATTR-CM
▸ #BHB/HRS1893 — Non-obstructive HCM
🌍 Global Insights — May 11
▸ #THESUSHFII — Acute HF in Africa
▸ #NEDA — Treatment trends & outcomes from Australia
The theme says it all: “Evolution in Heart Failure” 🚀
#HeartFailure2026 #ESCHeartFailure #HFA #Cardiology #CardioTwitter #LateBreakingScience #HFpEF #ATTRCM #HCM #AcuteHeartFailure

[HEART FAILURE BWGHF @BWGHF]

🚀 Webinaire: L'IA en Insuffisance Cardiaque ! Rejoignez-nous pour une discussion approfondie sur l'impact de l'intelligence artificielle dans notre pratique quotidienne.
📅 Jeudi 21 mai
⏰ 19h30 - 20h45
📍 Online #AI
#heartfailure https://t.co/ud9WYbhBQQ

[HEART FAILURE BWGHF @BWGHF]

🚩Ce soir, le 3ème épisode des « LES LIAISONS DANGEREUSES » non pas le film mais notre webinaire ! ❤️‍🩹COEUR ET MÉTABOLISME
Accréditation demandée
#Cardiologie #Expertise #insuffisancecardiaque #Cardiology #HeartFailure #Heart #Metabolism #Bwghf https://t.co/FVyBtDPbgk

[HEART FAILURE BWGHF @BWGHF]

🚩Ce soir, le 3ème épisode des « LES LIAISONS DANGEREUSES » non pas le film mais notre webinaire ! ❤️‍🩹COEUR ET MÉTABOLISME
Accréditation demandée
#Cardiologie #Expertise #insuffisancecardiaque #Cardiology #HeartFailure #Heart #Metabolism #Bwghf
https://t.co/FVyBtDPbgk

[HEART FAILURE BWGHF @BWGHF]

Les cardiologues défendent l’usage des statines face aux déclarations de Mr Vandenbroucke. Ces propos qui risquent de pousser certains patients à interrompre leur traitement. @rtlinfo @lesoir @lalibrebe @bscardio #Santé #politique #Prévention #Belgique https://t.co/zBOuEkATGr

[HEART FAILURE BWGHF @BWGHF]

Clôture des #JFICCAT2025 à Poitiers ! Discussions passionnantes sur l’IA, la télémédecine et les approches diagnostiques &amp; thérapeutiques innovantes en insuffisance cardiaque. Un grand merci au @Giccardio_fr pour ce congrès inspirant ! #Cardiologie #insuffisancecardiaque

[Le Spécialiste @JdS_SK]

Les cardiologues défendent l’usage des statines face aux critiques du ministre - https://t.co/No4BgCxw1n